The estimated Net Worth of Adam Scott Levy is at least $24.8 mil dollars as of 13 February 2018. Mr. Levy owns over 9,090 units of Brickell Biotech Inc stock worth over $24,769 and over the last 8 years he sold BBI stock worth over $0. In addition, he makes $0 as Chief Business Officer at Brickell Biotech Inc.
Sign up
Mr. Levy BBI stock SEC Form 4 insiders trading
Adam has made over 2 trades of the Brickell Biotech Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 9,090 units of BBI stock worth $49,995 on 13 February 2018.
The largest trade he's ever made was buying 9,090 units of Brickell Biotech Inc stock on 13 February 2018 worth over $49,995. On average, Adam trades about 1,032 units every 26 days since 2017. As of 13 February 2018 he still owns at least 10,540 units of Brickell Biotech Inc stock.
You can see the complete history of Mr. Levy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Adam Levy biography
Adam Scott Levy is Chief Business Officer of the Company. Mr. Levy has served as Brickell’s Chief Business Officer since 2019. Prior to joining Brickell, Mr. Levy served as Chief Business Officer at miRagen Therapeutics, a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need, from 2016 through 2019. Between 2000 through 2016, Mr. Levy held multiple Investment Banking positions at Merrill Lynch, Pierce, Fenner & Smith Incorporated, Jefferies Group and Wedbush Securities Inc. Mr. Levy received a B.S. in applied economics from Cornell University.
How old is Adam Levy?
Adam Levy is 41, he's been the Chief Business Officer of Brickell Biotech Inc since 2019. There are 14 older and 3 younger executives at Brickell Biotech Inc. The oldest executive at Brickell Biotech Inc is Albert Nicholas Marchio II, 69, who is the Chief Financial Officer.
What's Adam Levy's mailing address?
Adam's mailing address filed with the SEC is C/O BRICKELL BIOTECH, INC., 5777 CENTRAL AVENUE, SUITE 102, BOULDER, CO, 80301.
Insiders trading at Brickell Biotech Inc
Over the last 5 years, insiders at Brickell Biotech Inc have traded over $0 worth of Brickell Biotech Inc stock and bought 584,350 units worth $353,337 . The most active insiders traders include Vijay B Samant, Monica E. Luchi, eGary A Lyons. On average, Brickell Biotech Inc executives and independent directors trade stock every 16 days with the average trade being worth of $51,782. The most recent stock trade was executed by Reginald L Hardy on 23 July 2021, trading 200,000 units of BBI stock currently worth $134,000.
What does Brickell Biotech Inc do?
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell's executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®. Brickell's strategy is to leverage this experience to in-license, acquire, develop and commercialize innovative and differentiated pharmaceutical products that Brickell believes can be successful in the marketplace and transform lives by solving currently unmet patient needs.
What does Brickell Biotech Inc's logo look like?
Complete history of Mr. Levy stock trades at Miragen Therapeutics Inc e Brickell Biotech Inc
Brickell Biotech Inc executives and stock owners
Brickell Biotech Inc executives and other stock owners filed with the SEC include:
-
Vijay Samant,
Director -
Attorney Robert Busard Brown,
CEO & Director -
Deepak Chadha,
Chief R&D Officer -
Reginald L. Hardy M.B.A., R.Ph.,
Co-Founder & Chairman -
Dennison Veru,
Director -
Gary Lyons,
Director -
Adam Levy,
Chief Business Officer -
Deepak Chadha,
Chief Research and Development Officer -
David McAvoy,
Chief Compliance Officer, General Counsel, Assistant Secretary -
Jose Breton,
Chief Accounting Officer, Controller -
R. Carruthers,
Chief Financial Officer -
Andrew Sklawer,
Co-Founder, Chief Operating Officer, Secretary -
Robert Brown,
Chief Executive Officer, Director -
Reginald Hardy,
Chairman of the Board, Co-Founder -
Sue Fattor,
Head of Human Resource -
Aron Aizenstat M.B.A., P.M.P.,
VP of Corp. Devel. & Operations -
Gary S. Walker,
Chief Marketing Officer -
David R. Mcavoy J.D.,
Gen. Counsel & Chief Compliance Officer -
Jose Breton,
Controller & Chief Accounting Officer -
Albert Nicholas Marchio II,
Chief Financial Officer -
Sanjeev Ahuja,
Chief Medical Officer -
George B Abercrombie,
CHIEF EXECUTIVE OFFICER -
Monica E. Luchi,
Chief Medical Officer -
Albert N Ii Marchio,
Chief Financial Officer